Stock News - RHYTHM PHARMACEUTICALS, INC. $RYTM
Latest Stock News for $RYTM
Rhythm Pharmaceuticals Appoints Kim Popovits to Board, Ed Mathers Resigns
Expected Stock impact: Slightly Positive
2026-04-03 19:08:09
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE Expansion
Expected Stock impact: Noticeably Positive
2026-03-26 20:09:25
Rhythm Pharmaceuticals Receives FDA Approval for Expanded Indication of IMCIVREE to Treat Acquired Hypothalamic Obesity
Expected Stock impact: Very Positive
2026-03-20 14:49:16
Rhythm Pharmaceuticals Reports EMANATE Trial Results; Substudies Fail Primary Endpoints
Expected Stock impact: Slightly Negative
2026-03-16 20:38:45
